You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
東陽光藥(01558.HK)料中績多賺六成股價回吐近8%
阿思達克 07-24 14:44

東陽光藥(01558.HK)料中績多賺逾60%,但該股繼上周五創52周高位遇阻後,今天顯著回吐,一舉失守20天及10天線(40.92元及41.85元),最低見39.5元,現造39.8元,跌7.8%,成交急增至494萬股,創逾三個月高,涉資逾2億元。

東陽光藥指,受惠核心產品可威之銷售額持續增長、公司產品於全國醫療機構滲透率不斷提升,以及持續加強在專業學術市場推廣其產品,預計中期純利按年增長逾60%。

按東陽光藥去年中期純利6.35億人民幣計算,今年中期純利超過10.16億人民幣。不過,公司今年首季已賺7.76億人民幣,即次季只賺2.4億人民幣,按季倒退69%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account